Apollo AyurVAID Enters Ayurveda Product Segment

By Avinash S A / July 16, 2025

🏥 Apollo AyurVAID Enters Ayurveda Product Segment

Initial investment: ₹15 crore to build the Ayurveda products division. (The Economic Times)
Revenue target: Aim to achieve ₹500 crore in revenue over the next five years. (The Economic Times)

Product range includes:
- Classical prescription formulations
- OTC goods & medical foods
- Formats such as creams, transdermal pads, botanical extracts tailored for women, children, elderly, and therapies like pain relief, stress management, and skincare. (The Tribune, Deccan Herald)
Safety-first approach:
- The products are “tested safe” in NABL-accredited labs, screening for heavy metals, aflatoxins, microbial contaminants.
- Consumer-accessible QR-coded lab reports ensure transparency. (The Tribune)

Market size: India’s Ayurveda products market stands around ₹60,000 crore with a growth rate of 16%+ per year. (The Economic Times)

Collaboration: Partnered with Avesthagen to co-develop scientifically validated, sugar-free dietary supplements (under ‘AvestaAyurVAID’) and medical foods. (The Tribune)
Branding strategy:
- Prescription and OTC products under the brand “AyurVAID”
- Dietary supplements under “AvestaAyurVAID” (The Tribune)

Hospital network growth: Plan to establish 9 new centers this fiscal in an asset-light model, boosting bed capacity from 185 to 350 by FY26, and hitting 1,000 beds by 2028. (Deccan Herald)
Patient reach: Serving ~40,000–50,000 patients annually now, targeting 200,000+ in the next five years. (Apollo AyurVAID Hospitals)
Revenue momentum: Recording ~75% CAGR in recent years; on pace to exceed ₹100 crore annual revenue by mid‑FY26. (The Economic Times)

Evidence-based positioning: The move aims to broaden Apollo AyurVAID’s integrated, precision‑Ayurveda model from clinical care to consumer products with rigorous quality standards. (The Economic Times)
Distribution channels: Products to be available through:
- AyurVAID hospitals & clinics
- Apollo Pharmacies and Apollo 24|7
- Major e-commerce platforms (The Tribune)

Mainstreaming Ayurveda: This strategic expansion marks a significant shift, extending traditional Ayurvedic care into rigorously tested, standardised products—enhancing consumer confidence.
Market differentiation: Transparency via lab-test QR codes and validated safety sets these products apart in a largely unregulated space.
Widespread consumer access: With a multi-channel rollout, Ayurveda remedies become more accessible beyond clinical settings.